Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Liver Cancer treatment details. Biologic therapy. Memorial Sloan-Kettering Cancer Center, New York, NY, United States

Survival: 8.0 months
Toxicity Grade: 5
Treatments: Biologic therapy
Country: United States
City/State/Province: New York, NY
Hospital: Memorial Sloan-Kettering Cancer Center
Journal: Link
Date: 2/2014

This phase 2 study involved 24 advanced hepatocellular carcinoma patients. The median patient age was 67.5 years and 83% were male.

Patients received biologic therapy with cixutumumab, which is a monoclonal antibody to the IGF-1R protein that inhibits cancer cell growth.

There was one treatment-related death due to kidney failure. Grade 3 high blood glucose and grade 3-4 liver toxicities were also reported.

The median overall survival was 8 months.

This study was partially supported by ImClone Systems, makers of cixutumumab.

Correspondence: Dr. Ghassan K. Abou-Alfa; email:

E-mail to a Friend Email Physician More Information